Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CL) had its price target raised by Deutsche Bank Aktiengesellschaft from $83.00 to $90.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a hold rating on the stock.

CL has been the subject of several other research reports. Raymond James Financial lowered their target price on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. Jefferies Financial Group set a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, December 16th. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $88.00 to $93.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. The Goldman Sachs Group restated a “buy” rating and issued a $94.00 target price on shares of Colgate-Palmolive in a research report on Saturday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.13.

Colgate-Palmolive Stock Up 1.6%

Shares of CL opened at $91.75 on Monday. The firm has a 50 day simple moving average of $81.02 and a two-hundred day simple moving average of $81.37. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. Colgate-Palmolive has a one year low of $74.54 and a one year high of $100.18. The company has a market cap of $73.96 billion, a P/E ratio of 35.02, a P/E/G ratio of 6.09 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter last year, the business posted $0.91 EPS. The company’s revenue was up 5.8% compared to the same quarter last year. Research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s payout ratio is currently 79.39%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Westside Investment Management Inc. increased its stake in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares during the period. Maseco LLP bought a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Copia Wealth Management acquired a new stake in Colgate-Palmolive during the 3rd quarter valued at approximately $29,000. Vermillion & White Wealth Management Group LLC raised its holdings in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after purchasing an additional 155 shares during the last quarter. Finally, Cloud Capital Management LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $30,000. 80.41% of the stock is owned by institutional investors.

Key Stories Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Large-cap brokers raised targets/ratings — Bank of America moved its target to $100 and kept a Buy rating (about ~9% upside), signaling confidence in the company’s growth drivers. Bank of America raises PT to $100
• Positive Sentiment: Evercore lifted its target to $100 and set an Outperform rating, another high-profile shop adding upside to consensus. Evercore raises PT to $100
• Positive Sentiment: JPMorgan raised its price target to $97 and put CL at Overweight, adding institutional weight behind the post-earnings view. JPMorgan raises PT to $97
• Positive Sentiment: Colgate reported Q4 results that beat estimates (EPS $0.95 vs. $0.91 expected; revenue $5.23B vs. $5.13B expected) and organic sales growth, which prompted analysts to boost forecasts. Earnings strength is the primary catalyst for the upgrades. Analysts Boost Forecasts After Q4 Beat
• Positive Sentiment: Sell-side commentary (TD Cowen, Bank of America research notes) emphasizes premiumization, emerging-market strength and pet nutrition as multi-year growth levers supporting Buy ratings. Analyst thematic support
• Neutral Sentiment: Jefferies raised its target modestly to $91 but keeps a Hold rating; the new target is near the current price, implying limited near-term upside. Jefferies raises PT to $91 (Hold)
• Neutral Sentiment: Deutsche Bank raised its target to $90 and remains a Hold, another signal that some shops see less immediate upside despite the beat. Deutsche Bank raises PT to $90
• Negative Sentiment: Press coverage highlights lingering consumer uncertainty that could pressure volumes/mix going forward, a reminder that macro headwinds remain despite the beat. Consumer uncertainty clouds outlook

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.